Suchergebnisse - "Holekamp, Nancy"

PubPharm (126)

1

Correction to : Comparative Efficacy, Durability and Safety of Faricimab in the Treatment of Diabetic Macular Edema: A Systematic Literature Review and Network Meta-Analysis

enthalten in: Advances in therapy | 2024

von Watkins, C. | Paulo, T. | Bührer, C. | +2

ErratumFor: Adv Ther. 2023 Dec;40(12):5204-5221. - PMID 37751021

2

Correction to: Comparative Efficacy, Durability and Safety of Faricimab in the Treatment of Diabetic Macular Edema: A Systematic Literature Review and Network Meta-Analysis

enthalten in: Advances in therapy | 2024

von Watkins, C. | Paulo, T. | Bührer, C. | +2

3

Suprachoroidal Space Injection Technique : Expert Panel Guidance

enthalten in: Retina (Philadelphia, Pa.) | 2024

von Wykoff, C. | Avery, R. | Barakat, M. | +13

4

The 0.19-mg Fluocinolone Acetonide Intravitreal Implant for Diabetic Macular Edema : Intraocular Pressure-Related Effects over 36 Months

enthalten in: Ophthalmology. Retina | 2024

von Roth, D. | Eichenbaum, D. | Malik, D. | +56

5

Greater reduction in hyperreflective foci with faricimab compared to aflibercept in patients with diabetic macular oedema

enthalten in: Acta Ophthalmologica | 2024

von Schulthess, E. | Maunz, A. | Chakravarthy, U. | +9

6

Comparative Efficacy, Durability and Safety of Faricimab in the Treatment of Diabetic Macular Edema : A Systematic Literature Review and Network Meta-Analysis

enthalten in: Advances in therapy | 2023

von Watkins, C. | Paulo, T. | Bührer, C. | +2

ErratumIn: Adv Ther. 2024 May;41(5):2084-2085. - PMID 38480662

7

Progression of Geographic Atrophy : Retrospective Analysis of Patients from the IRIS® Registry (Intelligent Research in Sight)

enthalten in: Ophthalmology science | 2023

von Rahimy, E. | Khan, M. | Ho, A. | +8

8

Comparative Efficacy, Durability and Safety of Faricimab in the Treatment of Diabetic Macular Edema: A Systematic Literature Review and Network Meta-Analysis

enthalten in: Advances in therapy | 2023

von Watkins, C. | Paulo, T. | Bührer, C. | +2

9

Corrigendum to "The 0.19-mg Fluocinolone Acetonide Intravitreal Implant Reduces Treatment Burden in Diabetic Macular Edema" [Am J Ophthalmol 2023;248;16-23

enthalten in: American journal of ophthalmology | 2023

von Merrill, P. | Holekamp, N. | Roth, D. | +3

ErratumFor: Am J Ophthalmol. 2023 Apr;248:16-23. - PMID 36223849

10

BETTER BASELINE VISION LEADS TO BETTER OUTCOMES AFTER THE 0.19-mg FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT IN DIABETIC MACULAR EDEMA

enthalten in: Retina (Philadelphia, Pa.) | 2023

von Gonzalez, V. | Luo, C. | Almeida, D. | +58

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[13]